Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Burcham

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Pharmaceutical Sciences|June 13, 2009
Particle engineering: a strategy for establishing drug substance physical property specifications during small molecule developmentRonald G Iacocca, Christopher L Burcham, Lori R Hilden
Annual Review of Chemical and Biomolecular Engineering|June 8, 2018
Continuous Manufacturing in Pharmaceutical Process Development and ManufacturingChristopher L Burcham, Alastair J Florence, Martin D Johnson
Orthopedic Nursing|November 1, 1995
Telephone triage of upper extremity problemsC W Smith, L Burcham, J A Chase, et al.
Biopharmaceutics & Drug Disposition|November 28, 1997
Improved oral bioavailability of the hypocholesterolemic DMP 565 in dogs following oral dosing in oil and glycol solutionsD L Burcham, M B Maurin, E A Hausner, et al.
Biopharmaceutics & Drug Disposition|August 1, 1993
Metabolism and disposition of EXP631--a novel antidepressant analgesicY N Wong, D L Burcham, S M Huang, et al.
The Medical Journal of Australia|June 5, 1989
Incidence and risk factors for human immunodeficiency virus seroconversion in a cohort of Sydney homosexual menJ L Burcham, B Tindall, M Marmor, et al.
Biopharmaceutics & Drug Disposition|January 1, 1994
The pharmacokinetics and metabolism of DuP 532, a non-peptide angiotensin II receptor antagonist, in rats and dogsY N Wong, K A Holm, D L Burcham, et al.
Pharmaceutical Research|December 1, 1995
The effect of absorption enhancers on the oral absorption of the GP IIB/IIIA receptor antagonist, DMP 728, in rats and dogsD L Burcham, B A Aungst, M Hussain, et al.
The American Journal of Cardiology|April 22, 2005
Long-term effects of carvedilol or metoprolol on left ventricular function in ischemic and nonischemic cardiomyopathyPhilip Green, Michael Anshelevich, Ashok Talreja, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1994
Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogsM F Grubb, Y N Wong, D L Burcham, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Pharmaceutical Sciences|June 13, 2009
Particle engineering: a strategy for establishing drug substance physical property specifications during small molecule developmentRonald G Iacocca, Christopher L Burcham, Lori R Hilden
Annual Review of Chemical and Biomolecular Engineering|June 8, 2018
Continuous Manufacturing in Pharmaceutical Process Development and ManufacturingChristopher L Burcham, Alastair J Florence, Martin D Johnson
Orthopedic Nursing|November 1, 1995
Telephone triage of upper extremity problemsC W Smith, L Burcham, J A Chase, et al.
Biopharmaceutics & Drug Disposition|November 28, 1997
Improved oral bioavailability of the hypocholesterolemic DMP 565 in dogs following oral dosing in oil and glycol solutionsD L Burcham, M B Maurin, E A Hausner, et al.
Biopharmaceutics & Drug Disposition|August 1, 1993
Metabolism and disposition of EXP631--a novel antidepressant analgesicY N Wong, D L Burcham, S M Huang, et al.
The Medical Journal of Australia|June 5, 1989
Incidence and risk factors for human immunodeficiency virus seroconversion in a cohort of Sydney homosexual menJ L Burcham, B Tindall, M Marmor, et al.
Biopharmaceutics & Drug Disposition|January 1, 1994
The pharmacokinetics and metabolism of DuP 532, a non-peptide angiotensin II receptor antagonist, in rats and dogsY N Wong, K A Holm, D L Burcham, et al.
Pharmaceutical Research|December 1, 1995
The effect of absorption enhancers on the oral absorption of the GP IIB/IIIA receptor antagonist, DMP 728, in rats and dogsD L Burcham, B A Aungst, M Hussain, et al.
The American Journal of Cardiology|April 22, 2005
Long-term effects of carvedilol or metoprolol on left ventricular function in ischemic and nonischemic cardiomyopathyPhilip Green, Michael Anshelevich, Ashok Talreja, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1994
Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogsM F Grubb, Y N Wong, D L Burcham, et al.
Pageof 2